1.重庆医科大学,重庆
2.重庆市人民医院神经外科,重庆市脑胶质瘤精准医学研究中心,重庆
WU Nan, E-mail:wunan@cqu.edu.cn
Received:13 November 2025,
Revised:2026-01-28,
Published:30 March 2026
移动端阅览
赵璐,汪攀,龚胜,等.缺氧诱导因子-2α经转化生长因子-β2促进胶质母细胞瘤细胞化疗抵抗[J].陆军军医大学学报,2026,48(06):701-708.DOI:10.16016/j.2097-0927.202511068.
ZHAO L,WANG P,GONG S,et al.Hypoxia-inducible factor-2α promotes chemoresistance in glioblastoma cells via transforming growth factor-β2[J].J Army Med Univ,2026,48(06):701-708.DOI:10.16016/j.2097-0927.202511068.
赵璐,汪攀,龚胜,等.缺氧诱导因子-2α经转化生长因子-β2促进胶质母细胞瘤细胞化疗抵抗[J].陆军军医大学学报,2026,48(06):701-708.DOI:10.16016/j.2097-0927.202511068. DOI:
ZHAO L,WANG P,GONG S,et al.Hypoxia-inducible factor-2α promotes chemoresistance in glioblastoma cells via transforming growth factor-β2[J].J Army Med Univ,2026,48(06):701-708.DOI:10.16016/j.2097-0927.202511068. DOI:
目的
2
肿瘤微环境中的缺氧是导致胶质母细胞瘤化疗抵抗的关键因素。本研究通过体外研究初步探讨缺氧条件下缺氧诱导因子-2α(hypoxia-inducible factor-2α,HIF-2α)与转化生长因子-β2(transforming growth factor-β2,TGF-β2)促进胶质母细胞瘤细胞化疗抵抗。
方法
2
常氧-缺氧培养U87、U118细胞(
n
=3)并予替莫唑胺处理24、48、72 h后经CCK-8检测细胞增殖,培养48 h后流式细胞仪检测细胞凋亡。常氧培养为对照,缺氧培养U87、U118细胞(
n
=3)4、8、12及24 h后采用RT-qPCR检测HIF-2α、TGF-β2表达,进一步缺氧培养12、24 h及48 h后,Western blot检测HIF-2α、TGF-β2表达。敲除HIF-2α、TGF-β2后,缺氧培养细胞(
n
=3)并给予替莫唑胺(temozolomide,TMZ)处理24、48、72 h后经CCK-8检测细胞增殖,培养24 h后在部分细胞的培养基中添加TGF-β2(50 ng/mL)继续缺氧培养细胞(
n
=3)24 h后流式细胞仪检测细胞凋亡。Western blot检测敲除HIF-2α细胞缺氧培养48 h后TGF-β2表达。
结果
2
CCK-8和流式细胞检测提示,低氧+TMZ组较常氧+TMZ组细胞的存活率增高(
P
<
0.05)、凋亡率降低(
P
<
0.05)。RT-qPCR检测显示,与常氧组相比,缺氧培养细胞的HIF-2α、TGF-β2表达随着缺氧时间的延长,表达水平逐渐升高(
P
<
0.05),Western blot也证实HIF-2α、TGF-β2表达缺氧培养后呈时间依赖性升高。敲除HIF-2α、敲除TGF
-β2表达后的细胞存活率较对照未敲除组降低(
P
<
0.05),细胞凋亡率较对照未敲除组升高(
P
<
0.05)。敲除HIF-2α细胞继续缺氧培养后提示TGF-β2表达较对照未敲除HIF-2α细胞组水平下降。
结论
2
HIF-2α经TGF-β2促进胶质母细胞瘤细胞化疗抵抗。
Objective
2
Hypoxia in the tumor microenvironment is a critical factor contributing to chemoresistance in glioblastoma. This study preliminarily investigates the role of hypoxia-inducible factor-2α (HIF-2α) and transforming growth factor-β2 (TGF-β2) in promoting chemotherapy resistance of glioblastoma cells under hypoxic conditions.
Methods
2
U87 and U118 cells
(n
=3
)
were cultured under normoxic and hypoxic conditions and treated with temozolomide (TMZ) for 24
48
and 72 h. Cell proliferation was assessed by CCK-8 assay
and apoptosis was detected by flow cytometry after 48 h of culture. Using normoxic culture as control
U87 and U118 cells (
n
=3) were subjected to hypoxic culture for 4
8
12
and 24 h
followed by RT-qPCR to measure HIF-2α and TGF-β2 mRNA expression. After further hypoxic culture for 12
24
and 48 h
the protein levels of HIF-2α and TGF-β2 were detected by Western blotting. After knockdown of HIF-2α and TGF-β2
the cells
(n
=3) were cultured under hypoxia and treated with TMZ for 24
48
and 72 h. Then
the cell proliferation was detected by CCK-8 assay. After 24 h of culture
TGF-β2 (50 ng/mL) was added to the culture medium of some cells
and the cells were further cultured under hypoxia for another 24 h
followed by flow cytometry for cell apoptosis. Western blotting was applied to detect TGF-β2 expression in HIF-2α knockdown cells after 48 h of hypoxic culture.
Results
2
CCK-8 and flow cytometry assays indicated that the hypoxia+TMZ group showed increased cell viability (
P
<
0.05) and decreased apoptotic rate compared to the normoxia+TMZ group (
P
<
0.05). RT-qPCR revealed that compared with the normoxia group
the expression levels of HIF-2α and TGF-β2 in hypoxia-cultured cells gradually increased with the prolongation of hypoxic time (
P
<
0.05)
and Western blotting also confirmed that the protein expression of HIF-2α and TGF-β2 increased in a time-dependent manner after hypoxic culture. Lower cell viability (
P
<
0.05) and higher apoptotic rate (
P
<
0.05) were observed in the HIF-2α-knockdown and TGF-β2-knockdown cells compared with the control non-knockdown group. Continued hypoxic culture of HIF-2α-knockdown cells indicated decreased TGF-β2 expression compared with the control non-knockdown HIF-2α group.
Conclusion
2
HIF-2α chemoresistance in glioblastoma cells
via
TGF-β2.
SCHAFF L R , MELLINGHOFF I K . Glioblastoma and other primary brain malignancies in adults: a review [J]. JAMA , 2023 , 329 ( 7 ): 574 - 587 . DOI: 10.1001/jama.2023.0023 http://dx.doi.org/10.1001/jama.2023.0023 .
CHEN M , LIU L , ZENG Y , et al . An inflammatory gene-related prognostic risk score model for prognosis and immune infiltration in glioblastoma [J]. Mol Carcinog , 2024 , 63 ( 2 ): 326 - 338 . DOI: 10.1002/mc.23655 http://dx.doi.org/10.1002/mc.23655 .
COLWELL N , LARION M , GILES A J , et al . Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells [J]. Neuro Oncol , 2017 , 19 ( 7 ): 887 - 896 . DOI: 10.1093/neuonc/now258 http://dx.doi.org/10.1093/neuonc/now258 .
WU H B , GUO C C , WANG C Y , et al . Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma [J]. Cancer Sci , 2023 , 114 ( 6 ): 2609 - 2621 . DOI: 10.1111/cas.15773 http://dx.doi.org/10.1111/cas.15773 .
YUE Q , WANG Z , SHEN Y , et al . Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention [J]. Adv Sci (Weinh) , 2024 , 11 ( 19 ): e2309290 . DOI: 10.1002/advs.202z309290 http://dx.doi.org/10.1002/advs.202z309290 .
DE M M , DAVIAUD C , MINNS H E , et al . Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma [J]. Cancer Lett , 2023 , 570 : 216329 . DOI: 10.1016/j.canlet.2023.216329 http://dx.doi.org/10.1016/j.canlet.2023.216329 .
VAUPEL P , MAYER A . Hypoxia in cancer: significance and impact on clinical outcome [J]. Cancer Metastasis Rev , 2007 , 26 ( 2 ): 225 - 239 . DOI: 10.1007/s10555-007-9055-1 http://dx.doi.org/10.1007/s10555-007-9055-1 .
DAVIS L , RECKTENWALD M , HUTT E , et al . Targeting HIF-2α in the tumor microenvironment: redefining the role of HIF-2α for solid cancer therapy [J]. Cancers , 2022 , 14 ( 5 ): 1259 . DOI: 10.3390/cancers14051259 http://dx.doi.org/10.3390/cancers14051259 .
KEITH B , JOHNSON R S , SIMON M C . HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression [J]. Nat Rev Cancer , 2011 , 12 ( 1 ): 9 - 22 . DOI: 10.1038/nrc3183 http://dx.doi.org/10.1038/nrc3183 .
APRELIKOVA O , WOOD M , TACKETT S , et al . Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection [J]. Cancer Res , 2006 , 66 ( 11 ): 5641 - 5647 . DOI: 10.1158/0008-5472.CAN-05-3345 http://dx.doi.org/10.1158/0008-5472.CAN-05-3345 .
RENFROW J J , SOIKE M H , DEBINSKI W , et al . Hypoxia-inducible factor 2α: a novel target in gliomas [J]. Future Med Chem , 2018 , 10 ( 18 ): 2227 - 2236 . DOI: 10.4155/fmc-2018-0163 http://dx.doi.org/10.4155/fmc-2018-0163 .
TZAVLAKI K , MOUSTAKAS A . TGF-β signaling [J]. Biomolecules , 2020 , 10 ( 3 ): 487 . DOI: 10.3390/biom10030487 http://dx.doi.org/10.3390/biom10030487 .
WANG M Y , LIU W J , WU L Y , et al . The research progress in transforming growth factor-β2 [J]. Cells , 2023 , 12 ( 23 ): 2739 . DOI: 10.3390/cells12232739 http://dx.doi.org/10.3390/cells12232739 .
WANG P , LIAO B , GONG S , et al . Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1α/HIF2α regulation [J]. Cell Death Dis , 2025 , 16 ( 1 ): 317 . DOI: 10.1038/s41419-025-07617-w http://dx.doi.org/10.1038/s41419-025-07617-w .
YANG S X , ZHAN Q , SU D Y , et al . HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma [J]. Neuro Oncol , 2024 , 26 ( 8 ): 1405 - 1420 . DOI: 10.1093/neuonc/noae040 http://dx.doi.org/10.1093/neuonc/noae040 .
邓小玲 , 张能英 , 龙开国 , 等 . 缺氧微环境下HIF-1α与circ-UBE2G1相互调控促进甲状腺癌转移 [J]. 陆军军医大学学报 , 2025 , 47 ( 14 ): 1612 - 1622 . DOI: 10.16016/j.2097-0927.202504040 http://dx.doi.org/10.16016/j.2097-0927.202504040 .
DENG X L , ZHANG N Y , LONG K G , et al . Mutual regulation of HIF-1α and circ-UBE2G1 under hypoxic microenvironment promotes thyroid cancer metastasis [J]. J Army Med Univ , 2025 , 47 ( 14 ): 1612 - 1622 . DOI: 10.16016/j.2097-0927.202504040 http://dx.doi.org/10.16016/j.2097-0927.202504040 .
LISY K , PEET D J . Turn me on: regulating HIF transcriptional activity [J]. Cell Death Differ , 2008 , 15 ( 4 ): 642 - 649 . DOI: 10.1038/sj.cdd.4402315 http://dx.doi.org/10.1038/sj.cdd.4402315 .
WANG P , ZHAO L , GONG S , et al . HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia [J]. Cell Death Dis , 2021 , 12 ( 4 ): 312 . DOI: 10.1038/s41419-021-03598-8 http://dx.doi.org/10.1038/s41419-021-03598-8 .
WANG P , YAN Q , LIAO B , et al . The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions [J]. Cell Death Dis , 2020 , 11 ( 11 ): 992 . DOI: 10.1038/s41419-020-03150-0 http://dx.doi.org/10.1038/s41419-020-03150-0 .
GOLAN-C I , CAJA L . The TGF-beta family in glioblastoma [J]. Int J Mol Sci , 2024 , 25 ( 2 ): 1067 . DOI: 10.3390/ijms25021067 http://dx.doi.org/10.3390/ijms25021067 .
HAU P , JACHIMCZAK P , SCHLAIER J , et al . TGF-β2 signaling in high-grade gliomas [J]. Curr Pharm Biotechnol , 2011 , 12 ( 12 ): 2150 - 2157 . DOI: 10.2174/13892011179 8808347 http://dx.doi.org/10.2174/138920111798808347 .
ZHAO Y , WENG Z Y , ZHOU X , et al . Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2 [J]. J Transl Med , 2023 , 21 ( 1 ): 219 . DOI: 10.1186/s12967-023-04063-0 http://dx.doi.org/10.1186/s12967-023-04063-0 .
REN D N , YANG C , LIU N , et al . Gene expression profile analysis of U251 glioma cells with shRNA-mediated SOX9 knockdown [J]. J BUON , 2018 , 23 ( 4 ): 1136 - 1148 .
TANG Y A , CHEN Y F , BAO Y , et al . Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer [J]. Proc Natl Acad Sci USA , 2018 , 115 ( 26 ): E5990 - E5999 . DOI: 10.1073/pnas.1801348115 DOI:10.1073/pnas.1801348115 http://dx.doi.org/10.1073/pnas.1801348115DOI:10.1073/pnas.1801348115 .
0
Views
5
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
